The Efficacy of Inactivated EV71 Vaccine (KMB17) Against HFMD in Chinese Children and Infants

Clinical trial pipeline · Data from ClinicalTrials.gov

See which The Efficacy of Inactivated EV71 Vaccine (KMB17) Against HFMD in Chinese Children and Infants trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (2 shown)

CompletedPhase 2

NCT01512706

A Phase II, Safety and Efficacy Study of Inactivated EV 71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants

Enterovirus 71 (EV71), a major pathogen that is responsible for causing hand-foot-and-mouth disease (HFMD) worldwide, is a member of the Human Enterovirus speci…

China660 participantsStarted 2011-07

Treatment: 160Eu/0.5ml in infants (6-11 months old), 320Eu/0.5ml in infants (6-11 months old)

CompletedPhase 3

NCT01569581

A Protected Study of Inactivated EV71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants and Children

Enterovirus 71 (EV71), a major pathogen that is responsible for causing hand-foot-and-mouth disease (HFMD) worldwide, is a member of the Human Enterovirus speci…

China12,000 participantsStarted 2012-03

Treatment: 100U/0.5ml in 6-11 months old infants, 100U/0.5ml in 12-23 months old infants